AVDL
Avadel Pharm Sp ADR

3,509
Loading...
Loading...
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
188

Frequently Asked Questions

What is Market Cap of Avadel Pharmaceuticals plc?
What is the 52-week high for Avadel Pharmaceuticals plc?
What is the 52-week low for Avadel Pharmaceuticals plc?
What is Avadel Pharmaceuticals plc stock price today?
What was Avadel Pharmaceuticals plc stock price yesterday?
What is the PE ratio of Avadel Pharmaceuticals plc?
What is the Price-to-Book ratio of Avadel Pharmaceuticals plc?
What is the 50-day moving average of Avadel Pharmaceuticals plc?
How many employess does Avadel Pharmaceuticals plc has?

Latest AVDL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.